Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.630
-0.020 (-1.21%)
At close: Feb 13, 2026, 4:00 PM EST
1.750
+0.120 (7.36%)
After-hours: Feb 13, 2026, 7:50 PM EST
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $6.2 million as of February 13, 2026. Its market cap has decreased by -0.82% in one year.
Market Cap
6.20M
Enterprise Value
1.75M
1-Year Change
-0.82%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $6.20M, a decrease of -99.46%. That is a compound annual growth rate of -67.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 6.20M | -10.44% |
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | 1.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revelation Biosciences | 6.93M |
| Aptevo Therapeutics | 6.74M |
| PharmaCyte Biotech | 6.70M |
| Theriva Biologics | 6.53M |
| Immuron | 6.46M |
| Creative Medical Technology Holdings | 6.40M |
| Mustang Bio | 6.35M |
| MetaVia | 6.06M |